Glucagon-Like Peptide-1 Agonist (GLP-1)

DRUG2 trials

Sponsors

Janssen Research & Development, LLC, Johns Hopkins University

Conditions

Alcohol Use DisorderDiabetes Mellitus, Type 2

Phase 2

Combination Therapy for Alcohol Use Disorder

Not yet recruitingNCT07249554

Johns Hopkins UniversityAlcohol Use Disorder

Start: 2026-05-01End: 2028-06-01Target: 45Updated: 2026-03-09

Unknown Phase

Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)

CompletedNCT03249506

Janssen Research & Development, LLCDiabetes Mellitus, Type 2

Start: 2016-05-12End: 2017-11-01Updated: 2017-11-21